Pfizer and BioNTech have struck a deal for South Africa’s Biovac Institute to help manufacture around 100 million doses a year of their Covid-19 vaccine for the African Union.
Get the best South African technology news and analysis delivered to your e-mail inbox every morning.
Pfizer and BioNTech have struck a deal for South Africa’s Biovac Institute to help manufacture around 100 million doses a year of their Covid-19 vaccine for the African Union.